Atlas Oncology Holdings Inc. — Form D

Atlas Oncology Holdings Inc. of NASHVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-25. The offering totals $23.0M, of which $23.0M was reported sold. Industry: Other.

Offering

• Filed: 2026-02-25
• Form: D
• Accession: 0002110866-26-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $23.0M
• Amount sold: $23.0M
• Investors: 3
• Date of first sale: 2026-02-10
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-574621

Issuer

• Name: Atlas Oncology Holdings Inc.
• CIK: 0002110866
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 1316 ADAMS STREET, NASHVILLE, TN, 37208
• Phone: 615-864-0524

Officers, directors & promoters (13)

More

• CIK 2110866 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search